NCT07851519

Brief Summary

This pilot study aims to evaluate whether a standardized proactive moisture-care protocol using a silicone-based skin barrier spray can reduce early-stage pressure injuries (PIs) in the perineal-sacral area among incontinent inpatients. Incontinence leads to prolonged exposure of skin to moisture and irritants, resulting in Incontinence-Associated Dermatitis (IAD) and increased vulnerability to PIs. Currently, barrier products are applied reactively after skin redness appears. The proposed intervention introduces a proactive approach-daily application of barrier spray during routine morning care before visible damage occurs. Forty inpatients aged65 or above will be recruited from an acute medical ward over 12weeks. Participants admitted in weeks1-6 will receive usual care (control), and those in weeks7-12 will receive the proactive protocol (intervention). Each will be observed for up to14days or until discharge or skin breakdown. The primary outcome is the incidence of new Stage1-2PIs in the perineal-sacral area; secondary outcomes include IAD incidence, nursing compliance, workload, and cost comparisons. This minimal-risk study uses only approved hospital products, follows standard hygiene and safety procedures, and emphasizes proactive prevention to enhance patient outcomes, nursing efficiency, and resource sustainability. Results will guide future large-scale implementation of standardized moisture-care practices.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jul 2026Nov 2026

Study Start

First participant enrolled

July 20, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

September 25, 2026

Last Update Submit

September 25, 2026

Conditions

Keywords

Pressure Injury PreventionIncontinence-Associated DermatitisSkin Barrier SprayMoisture-Care ProtocolIncontinent CareNursing Care Protocol

Outcome Measures

Primary Outcomes (1)

  • Incidence of New Stage 1-2 Perineal-Sacral Pressure Injuries

    Percentage of participants who develop a new Stage 1 or Stage 2 pressure injury in the perineal-sacral area, classified using the NPIAP Pressure Injury Staging System.

    Up to 14 days (from admission until hospital discharge or first sign of skin breakdown, whichever occurs first)

Study Arms (2)

Usual care

ACTIVE COMPARATOR

This arm receives active usual care (standard cleansing + reactive application of barrier creams upon early signs of redness).

Other: Usual Care

Intervention Group

EXPERIMENTAL

Standard moisture care protocol with proactive daily application of Skin Barrier spray every morning to intact perineal-sacral skin. Observation lasts up to 14 days, until hospital discharge, or until skin breakdown occurs.

Other: Intervention Group

Interventions

Standard reactive nursing care involving no-rinse skin cleansing, with skin barrier products (zinc oxide or barrier cream) applied only upon clinical identification of early skin redness or irritation.

Usual care

A proactive moisture-care protocol comprising routine no-rinse skin cleansing and once-daily application of a silicone-based skin barrier spray every morning following incontinence care to all intact perineal-sacral skin.

Intervention Group

Eligibility Criteria

Age65 Days+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 65 years or older.
  • Braden Scale total score of 18 or below at admission screening.
  • Presence of urinary incontinence, fecal incontinence, or both, requiring napkin use.
  • Intact perineal-sacral skin at the time of enrolment.

You may not qualify if:

  • Presence of an indwelling urinary catheter.
  • Active diarrhea at the time of screening.
  • Documented allergy or sensitivity to skin barrier products.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

United Christian Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Advanced Practice Nurse

Study Record Dates

First Submitted

September 25, 2026

First Posted

October 1, 2026

Study Start

July 20, 2026

Primary Completion (Estimated)

October 4, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations